Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
about
"Stormy waters ahead": global emergence of carbapenemasesNew treatment options against gram-negative organismsGenetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A -Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in FranceBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaCarbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.Risk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258.Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipientsInhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.Molecular epidemiology of KPC-producing Escherichia coli: occurrence of ST131-fimH30 subclone harboring pKpQIL-like IncFIIk plasmid.Clonality and Resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing.Carbapenem Resistance among Enterobacter Species in a Tertiary Care Hospital in Central India.Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.Carbapenem-resistant enterobacteriaceae: an emerging problem in children.Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features.Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study"Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance ProgramGenetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from AustraliaPrevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.Current concepts in antibiotic-resistant gram-negative bacteria.Optimization of pulse-field gel electrophoresis for subtyping of Klebsiella pneumoniae.Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.Detection of plasmid-mediated IMP-1 metallo-beta-lactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate.Resistance plasmid families in EnterobacteriaceaeMultiresistant Enterobacteriaceae: new threat of an old problem.Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.IMP-type metallo-β-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons.Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance.Phenotypic detection and molecular characterization of beta-lactamase genes among Citrobacter species in a tertiary care hospital.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Emerging drugs for nosocomial pneumonia.Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
P2860
Q21131125-97B26C5D-64C4-4458-A204-080E5912DF3BQ21194906-5F624E22-47A3-4107-BFE5-86D186801816Q27651194-759E90F4-78D2-4507-8349-D93924CA6A84Q29616084-CE7AD959-2AC4-4F97-A23B-A1A1E20F94C2Q30148824-36DAE846-F513-4F02-83B6-5A896F9130B2Q30384546-BB0D30C2-BC7A-423A-8E74-43A2CDCD2235Q30433281-74443705-D67B-4174-9BF2-A55AB7333630Q33613797-C7BAEFD2-621A-4E27-8050-F4BED9400DB5Q33798509-4BB6DDA9-4406-479D-9902-5D7EFE37EA05Q33930400-4A4D4467-1B18-4810-A1B0-D495529B57FBQ34080525-1D2D11B9-F0F5-46E7-9C8D-CEEAC6B5DB03Q34109281-6CBA9FCF-95F3-4263-B97F-F680A36BE720Q34281727-F1A3B409-0008-49B3-92C3-5CEB16DE7236Q34309597-AF786F6E-AD0E-48B3-B0B4-DE277D683472Q34433108-2BB99B60-DDB7-4BB6-A869-710A279C9A4BQ34641507-C54386ED-EA20-4F43-AF2E-FF9386F73EAEQ34788854-3DB070D1-DD89-490E-BB0B-8DB0EE8530CBQ34826917-37473E0E-9D3E-4818-ABB5-09DFDA32D7B9Q34869292-9863E392-4BF2-441E-9C95-475BCD1F4EEBQ35066558-6C8B19B2-E6D4-48AD-82A6-6F68A71C8C81Q36115511-4D55C2CF-DC72-4387-A1F9-98A3E49C52F8Q36355345-1FFBBE28-276E-4294-9704-001074C97A5AQ36425049-B21F8FB7-373C-4FC8-9156-3840CF8A3CC5Q36538664-F6B2B557-4ED1-4020-AD18-926C1B2457F6Q36803980-0EFE02A3-5714-4D24-BCE0-DC522F51BA7DQ36949536-832EEE9A-8783-4813-9665-2FAF815E5C71Q36960068-A05BADAB-E286-4B8F-BC92-91F00177AD2EQ37072473-D94ED1E4-E0B4-474A-A905-20D2A4DF71DAQ37092395-138A4E05-44F6-4B8D-8E4A-A63D71D73F4EQ37177466-54B22457-3191-47E7-BD4B-BED1C44166D0Q37204254-5B3282D6-8F8D-4ADE-B0F4-38B0577C5472Q37291349-E8ACB7D3-DA29-4564-ABC0-F098C26C0AA7Q37544774-AA06FB7D-6B51-49FD-85F5-3E4786C999ADQ37894745-564387E6-D310-487B-B673-9A6550B35B52Q38029012-07074EE7-2FC6-4220-B7C0-3D1225BDD6FFQ38560661-5284395B-EEED-4C28-9CD3-0B366B228A6BQ38672016-854B8321-A7E0-4CFA-8F27-604D0D62CF5EQ38751264-F8EF3729-1A39-4094-A2D4-E59C6D26BC35Q38878167-4E7CCFF4-190C-45DF-AE38-EC750787A735Q38899499-1355FB60-6E29-473F-A0EF-A440F130A610
P2860
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Occurrence and characterizatio ...... veillance Program (2000-2004).
@en
Occurrence and characterizatio ...... microbial Surveillance Program
@nl
type
label
Occurrence and characterizatio ...... veillance Program (2000-2004).
@en
Occurrence and characterizatio ...... microbial Surveillance Program
@nl
prefLabel
Occurrence and characterizatio ...... veillance Program (2000-2004).
@en
Occurrence and characterizatio ...... microbial Surveillance Program
@nl
P2093
P356
P1476
Occurrence and characterizatio ...... veillance Program (2000-2004).
@en
P2093
Lalitagauri M Deshpande
Ronald N Jones
Thomas R Fritsche
P304
P356
10.1089/MDR.2006.12.223
P577
2006-01-01T00:00:00Z